Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm	Recruiting	Phase 3	2024-07-11		NCT06496308

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Cancer Hospital	32
Fujian Cancer Hospital	114
Fujian Medical University Union Hospital	108
Huadong Hospital Affiliated with Fudan University, Shanghai	3
Jiangxi Provincial Cancer Hospital	33
Ruijin Hospital	454
The First Affiliated Hospital of Anhui Medical University	85
The Third Xiangya Hospital of Central South University	75
Yantai Yuhuangding Hospital	32

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ruijin Hospital	Shanghai	China	8